Artal Group as of March 31, 2017
Portfolio Holdings for Artal Group
Artal Group holds 87 positions in its portfolio as reported in the March 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Blue Buffalo Pet Prods | 44.6 | $2.0B | 88M | 23.00 | |
| Lexicon Pharmaceuticals (LXRX) | 18.3 | $825M | 58M | 14.34 | |
| Weight Watchers International | 10.2 | $458M | 29M | 15.57 | |
| MetLife (MET) | 2.3 | $103M | 2.0M | 52.82 | |
| Bank of America Corporation (BAC) | 1.8 | $83M | 3.5M | 23.59 | |
| Goldman Sachs (GS) | 1.5 | $69M | 300k | 229.72 | |
| Bristol Myers Squibb (BMY) | 1.2 | $54M | 1.0M | 54.38 | |
| Agios Pharmaceuticals (AGIO) | 1.1 | $50M | 850k | 58.40 | |
| Wells Fargo & Company (WFC) | 1.0 | $45M | 800k | 55.66 | |
| Incyte Corporation (INCY) | 1.0 | $43M | 325k | 133.67 | |
| Alibaba Group Holding (BABA) | 1.0 | $43M | 400k | 107.83 | |
| Nektar Therapeutics (NKTR) | 0.8 | $35M | 1.5M | 23.47 | |
| Gilead Sciences (GILD) | 0.8 | $34M | 500k | 67.92 | |
| BioMarin Pharmaceutical (BMRN) | 0.7 | $33M | 375k | 87.78 | |
| Celgene Corporation | 0.7 | $31M | 250k | 124.43 | |
| Citigroup (C) | 0.7 | $30M | 500k | 59.82 | |
| Regeneron Pharmaceuticals (REGN) | 0.7 | $29M | 75k | 387.51 | |
| Bluebird Bio (BLUE) | 0.5 | $23M | 250k | 90.90 | |
| Athene Holding Ltd Cl A | 0.5 | $23M | 450k | 49.99 | |
| American Airls (AAL) | 0.5 | $21M | 500k | 42.30 | |
| Acceleron Pharma | 0.4 | $20M | 750k | 26.47 | |
| Tesaro | 0.4 | $18M | 116k | 153.88 | |
| JPMorgan Chase & Co. (JPM) | 0.4 | $18M | 200k | 87.84 | |
| International Business Machines (IBM) | 0.4 | $17M | 100k | 174.14 | |
| Facebook Inc cl a (META) | 0.4 | $18M | 125k | 142.05 | |
| Alnylam Pharmaceuticals (ALNY) | 0.3 | $15M | 300k | 51.25 | |
| Market Vectors Etf Tr Oil Svcs | 0.3 | $15M | 500k | 30.81 | |
| Sarepta Therapeutics (SRPT) | 0.3 | $15M | 500k | 29.60 | |
| Neurocrine Biosciences (NBIX) | 0.3 | $14M | 325k | 43.30 | |
| Amicus Therapeutics (FOLD) | 0.3 | $14M | 1.9M | 7.13 | |
| Beigene (BGNE) | 0.3 | $13M | 363k | 36.61 | |
| Sage Therapeutics (SAGE) | 0.3 | $12M | 175k | 71.07 | |
| Zto Express Cayman (ZTO) | 0.3 | $12M | 950k | 13.09 | |
| Alexion Pharmaceuticals | 0.3 | $12M | 100k | 121.24 | |
| Ironwood Pharmaceuticals (IRWD) | 0.3 | $12M | 717k | 17.06 | |
| Horizon Pharma | 0.3 | $12M | 800k | 14.78 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.2 | $11M | 100k | 109.35 | |
| Kite Pharma | 0.2 | $10M | 130k | 78.49 | |
| Atara Biotherapeutics (ATRA) | 0.2 | $10M | 500k | 20.55 | |
| Ionis Pharmaceuticals (IONS) | 0.2 | $10M | 250k | 40.20 | |
| Radius Health | 0.2 | $9.7M | 250k | 38.65 | |
| Avexis | 0.2 | $9.1M | 120k | 76.03 | |
| Agenus (AGEN) | 0.2 | $8.3M | 2.2M | 3.77 | |
| Ignyta | 0.2 | $8.1M | 937k | 8.60 | |
| Elf Beauty (ELF) | 0.2 | $7.2M | 250k | 28.80 | |
| Array BioPharma | 0.1 | $6.7M | 750k | 8.94 | |
| Seres Therapeutics (MCRB) | 0.1 | $6.8M | 600k | 11.27 | |
| Jounce Therapeutics | 0.1 | $6.6M | 300k | 21.99 | |
| Versartis | 0.1 | $6.4M | 300k | 21.35 | |
| Alder Biopharmaceuticals | 0.1 | $6.2M | 300k | 20.80 | |
| Global Blood Therapeutics In | 0.1 | $6.4M | 175k | 36.85 | |
| Macrogenics (MGNX) | 0.1 | $5.6M | 300k | 18.60 | |
| Juno Therapeutics | 0.1 | $5.5M | 250k | 22.19 | |
| Medicines Company | 0.1 | $4.9M | 100k | 48.90 | |
| Ac Immune Sa (ACIU) | 0.1 | $5.2M | 500k | 10.36 | |
| Seattle Genetics | 0.1 | $4.7M | 75k | 62.87 | |
| BioTime | 0.1 | $4.4M | 1.3M | 3.45 | |
| Zafgen | 0.1 | $4.7M | 1.0M | 4.66 | |
| BioCryst Pharmaceuticals (BCRX) | 0.1 | $4.2M | 500k | 8.40 | |
| Chemocentryx | 0.1 | $4.0M | 546k | 7.28 | |
| Aimmune Therapeutics | 0.1 | $3.9M | 182k | 21.73 | |
| Intel Corporation (INTC) | 0.1 | $3.6M | 100k | 36.07 | |
| Vital Therapies | 0.1 | $3.5M | 875k | 4.00 | |
| Cellectis S A (CLLS) | 0.1 | $3.6M | 150k | 24.00 | |
| Axovant Sciences | 0.1 | $3.7M | 250k | 14.94 | |
| Intellia Therapeutics (NTLA) | 0.1 | $3.5M | 250k | 14.09 | |
| Chimerix (CMRX) | 0.1 | $3.2M | 500k | 6.38 | |
| Regenxbio Inc equity us cm (RGNX) | 0.1 | $3.1M | 160k | 19.30 | |
| Loxo Oncology | 0.1 | $2.7M | 65k | 42.08 | |
| Spark Therapeutics | 0.1 | $2.7M | 50k | 53.34 | |
| Syndax Pharmaceuticals (SNDX) | 0.1 | $2.7M | 200k | 13.72 | |
| Noveliontherapeuti.. | 0.1 | $2.8M | 256k | 10.74 | |
| Celldex Therapeutics | 0.1 | $2.4M | 675k | 3.61 | |
| Ultragenyx Pharmaceutical (RARE) | 0.1 | $2.0M | 30k | 67.77 | |
| Minerva Neurosciences | 0.1 | $2.0M | 251k | 8.10 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.0 | $2.0M | 400k | 5.00 | |
| Adaptimmune Therapeutics (ADAP) | 0.0 | $1.7M | 300k | 5.51 | |
| Achaogen | 0.0 | $1.5M | 60k | 25.23 | |
| Anaptysbio Inc Common (ANAB) | 0.0 | $1.2M | 45k | 27.75 | |
| D Stemline Therapeutics | 0.0 | $855k | 100k | 8.55 | |
| Aduro Biotech | 0.0 | $1.1M | 100k | 10.75 | |
| Nantkwest | 0.0 | $799k | 225k | 3.55 | |
| Oncocyte | 0.0 | $893k | 150k | 5.95 | |
| Novavax | 0.0 | $640k | 500k | 1.28 | |
| Neuroderm Ltd F | 0.0 | $664k | 25k | 26.56 | |
| Xenon Pharmaceuticals (XENE) | 0.0 | $600k | 150k | 4.00 | |
| Dimension Therapeutics | 0.0 | $410k | 235k | 1.75 |
